§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US6311692B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Apparatus and method for diagnosis and therapy of electrophysiological disease

Assignee: St Jude Medical Atrial Fibrillation Division Inc
•
Filing: 1999-07-19
•
Granted: 2001-11-06
•
Expires: 2019-07-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.

Inventors

  • 👤 Matthias Vaska
  • 👤 Benjamin Pless
  • 👤 David A. Gallup
  • 👤 Jack E. Ulstad, Jr.
  • 👤 Scott C. Anderson
  • 👤 Roxanne L. Richman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:40
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/02; A61B18/04; A61B18/12; A61B18/14; A61B18/1402; A61B18/1482; A61B18/1492; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/06; A61N7/00; A61N7/02; A61B18/148; A61B17/00; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/00292; A61B2017/003; A61B17/34; A61B17/3417; A61B2017/3419; A61B2018/00005; A61B2018/00011; A61B2018/00023; A61B2018/00053; A61B2018/0016; A61B2018/00214; A61B2018/0022; A61B2018/00232; A61B2018/0025; A61B2018/00261; A61B2018/00273; A61B2018/00279; A61B2018/00285; A61B2018/00291; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00363; A61B2018/00392; A61B2018/00571; A61B2018/00577; A61B2018/00636; A61B2018/00642; A61B2018/00654; A61B2018/00773; A61B2018/00791; A61B2018/00797; A61B2018/00839; A61B2018/1405; A61B2018/142; A61B18/1442; A61B2018/145; A61B2018/1467; A61B2018/1472; A61B90/00; A61B90/36; A61B90/361; A61B2090/3614; A61B90/37; A61B2090/378; A61B2090/3782; A61B2218/00; A61B2218/001; A61B2218/002; A61B2218/007; A61B34/00; A61B34/20; A61B5/00; A61B5/24; A61B5/25; A61B5/279; A61B5/28; A61B5/283; A61B5/287; A61N1/18; A61N1/32; A61N1/36; A61N1/362; A61N1/3629

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 99 words
A method of ablating tissue from an epicardial location, comprising the steps of: providing an ablating device having an ablating element, the ablating device having a locking mechanism for locking a part of the ablating device to another part of the ablating device; positioning the ablating device around a portion of a patient's heart with the ablating element positioned against an epicardial location; locking the locking mechanism so that the ablating device forms a closed loop around a portion of the patient's heart with the ablating element positioned at the epicardial location and ablating tissue with the ablating device.
Claim 2
Independent Claim 99 words
A method of ablating tissue from an epicardial location, comprising the steps of: providing an ablating device having an ablating element, the ablating device having a locking mechanism for locking a part of the ablating device to another part of the ablating device; positioning the ablating device around a portion of a patient's heart with the ablating element positioned against an epicardial location; locking the locking mechanism so that the ablating device forms a closed loop around a portion of the patient's heart with the ablating element positioned at the epicardial location and ablating tissue with the ablating device.
Claim 3
Dependent Claim 60 words
The method of claim 1 , wherein: the providing step is carried out with the ablating device having a first ablating portion and a second ablating portion; and the ablating step being carried out by ablating tissue with the first and second ablating portions, the ablating element being positioned along at least one of the first and second ablating portions.
Claim 4
Dependent Claim 32 words
The method of claim 2 , wherein: the ablating step is carried out with the first ablating portion extending adjacent to the pericardial reflection extending between the RS and LS pulmonary veins.
Claim 5
Dependent Claim 30 words
The method of claim 2 , further comprising the step of: the locking step is carried out so that the ablating device encircles at least one of the pulmonary veins.
Claim 6
Dependent Claim 21 words
The method of claim 1 , wherein: the providing step is carried out with the ablating element having an RF electrode.
Claim 7
Dependent Claim 39 words
The method of claim 1 , wherein: the providing step is carried out with the ablating element being an element selected from the group consisting of RF electrode, microwave transmitter, laser, ultrasound transducer, direct contact heating, or cryogenic element.
Claim 8
Dependent Claim 23 words
The method of claim 1 , wherein: the locking step is carried out so that the ablating device encircles all four pulmonary veins.
Claim 9
Dependent Claim 22 words
The method of claim 1 , wherein: the positioning step is carried out by wrapping the ablating device around the patient's heart.
Claim 10
Dependent Claim 23 words
The method of claim 1 , wherein: the providing step is carried out with the ablating device having a plurality of ablating elements.
Claim 11
Dependent Claim 30 words
The method of claim 1 , wherein: the providing step is carried out with the ablating device having a width and a height, the width being larger than the height.
Claim 12
Dependent Claim 21 words
The method of claim 10 , wherein: the providing step is carried out with a width to height ratio being 2-5.

References Cited (Backward Citations)

US3862627A Cited
GB2094636A Cited
US4736749A Cited
US5231995A Cited
US4802475A Cited
US4815470A Cited
US5588432A Cited
US5147355A Cited
US5108390A Cited
US5224943A Cited
US5334181A Cited
US5465717A Cited
US5433708A Cited
US5450843A Cited
US5254116A Cited
US5520682A Cited
US5353783A Cited
US5730704A Cited
US5263493A Cited
US5555883A Cited
US5871525A Cited
US5423807A Cited
US5281215A Cited
US5295484A Cited
US5578007A Cited
US5324284A Cited
US5435308A Cited
US5676693A Cited
US5658278A Cited
US5697927A Cited
US5478330A Cited
US5348554A Cited
US5423811A Cited
US5656029A Cited
US6161543A Cited
US5630837A Cited
US5571088A Cited
US5487757A Cited
US5545200A Cited
US5921982A Cited
US5385148A Cited
US5928191A Cited
US5718701A Cited
US5431649A Cited
US5405376A Cited
US5437651A Cited
US5607462A Cited
US5582609A Cited
US5549661A Cited
US5871523A Cited
US5575810A Cited
US5575766A Cited
US5879296A Cited
US5536267A Cited
US5921924A Cited
WO1995015115A1 Cited
US5730127A Cited
US5487385A Cited
US5687723A Cited
US5643197A Cited
WO1995017222A1 Cited
GB2289510A Cited
WO1995030380A2 Cited
US5560362A Cited
US5617854A Cited
US5681278A Cited
US5681308A Cited
US5769846A Cited
US5680860A Cited
US5902289A Cited
US5690611A Cited
US5810802A Cited
US5885278A Cited
US5836947A Cited
US6142994A Cited
AU7052296A Cited
US5676662A Cited
US5916214A Cited
US5827216A Cited
US5697925A Cited
US5678550A Cited
US5927284A Cited
US5590657A Cited
US5716389A Cited
US5733280A Cited
US5895417A Cited
US5800482A Cited
US5755760A Cited
US5800428A Cited
US5730074A Cited
US5882346A Cited
US5720775A Cited
US5993447A Cited
US5697928A Cited
US5893848A Cited
US5931848A Cited
US5931810A Cited
US6071279A Cited
US5899899A Cited
US5897554A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2004-11-05 2005-05-07 2005-11-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2008-11-05 2009-05-07 2009-11-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2012-11-05 2013-05-07 2013-11-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag